iPath Pure Beta Sugar ETN
SGAR
New York Stock Exchange Arca- -
USD
- -
- -
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Sector
- Financial Services
- Industry
- Asset Management
- Address
- 50 Hudson Yards New York NY United States of America 10001
- IPO Date
- Apr 28, 2011
- Website
- barclaysinvestments.co.uk
- Similar Companies
- Business
- iPath Series B S&P GSCI Sugar Total Return ETN (SGAR) is an exchange-traded note issued by Barclays Bank PLC that provides exposure to the S&P GSCI Sugar Index Total Return, tracking the performance of sugar futures contracts. The ETN offers investors a leveraged way to gain access to sugar commodity prices through a single ticker on major U.S. exchanges; it employs a pure beta strategy without active management, rolling front-month futures contracts to maintain continuous exposure; and it pays any positive index performance quarterly as distributions while bearing the full downside risk. Headquartered in London, United Kingdom, with primary U.S. operations through Barclays PLC, the issuer was founded in 1690 as a predecessor entity, though the iPath ETN series launched in 2006 to serve institutional and retail investors in commodities. Barclays operates globally across North America, Europe, and Asia-Pacific in investment banking, wealth management, and structured products segments. In recent developments, Barclays announced enhancements to its iPath ETNs in 2024, including potential redemptions or accelerations for low-liquidity products amid market shifts; the firm completed a strategic restructuring of its investment banking division; and SGAR continues as an active listing following the transition from Series A to Series B ETNs in prior years to improve tax efficiency and operational stability.